Vera Therapeutics, Inc. (VERA) DCF Valuation

Vera Therapeutics, Inc. (VERA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Vera Therapeutics, Inc. (VERA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore the financial potential of Vera Therapeutics, Inc. (VERA) with our user-friendly DCF Calculator! Enter your projections for growth, profit margins, and expenses to calculate the intrinsic value of Vera Therapeutics, Inc. (VERA) and enhance your investment approach.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 1.9 1.9 1.9 1.9 1.9 1.9
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -11.2 -53.0 -34.2 -90.9 -102.0 1.1 1.1 1.1 1.1 1.1
EBITDA, % 100 100 100 100 -5478.63 60 60 60 60 60
Depreciation .5 .3 .2 -.8 .0 1.5 1.5 1.5 1.5 1.5
Depreciation, % 100 100 100 100 0 80 80 80 80 80
EBIT -11.7 -53.2 -34.4 -90.1 -102.0 1.1 1.1 1.1 1.1 1.1
EBIT, % 100 100 100 100 -5478.63 60 60 60 60 60
Total Cash 3.2 53.7 79.7 114.7 160.7 1.9 1.9 1.9 1.9 1.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .1 .0 .0 .0
Account Receivables, % 100 100 100 100 0
Inventories .0 .5 .0 .0 .0 1.5 1.5 1.5 1.5 1.5
Inventories, % 100 100 100 100 0 80 80 80 80 80
Accounts Payable .3 .9 1.4 12.0 11.1 1.9 1.9 1.9 1.9 1.9
Accounts Payable, % 100 100 100 100 597.1 100 100 100 100 100
Capital Expenditure -.1 -.1 .0 -.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 -3.38 -0.67669 -0.67669 -0.67669 -0.67669 -0.67669
Tax Rate, % -0.00104179 -0.00104179 -0.00104179 -0.00104179 -0.00104179 -0.00104179 -0.00104179 -0.00104179 -0.00104179 -0.00104179
EBITAT -11.7 -53.2 -34.4 -90.1 -102.0 1.1 1.1 1.1 1.1 1.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -11.0 -53.1 -33.2 -80.4 -102.9 -9.6 2.6 2.6 2.6 2.6
WACC, % 9.15 9.15 9.15 9.15 9.15 9.15 9.15 9.15 9.15 9.15
PV UFCF
SUM PV UFCF -1.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 3
Terminal Value 37
Present Terminal Value 24
Enterprise Value 23
Net Debt 8
Equity Value 15
Diluted Shares Outstanding, MM 43
Equity Value Per Share 0.34

What You Will Get

  • Comprehensive VERA Financials: Access to both historical and projected data for precise valuation.
  • Customizable Inputs: Adjust variables such as WACC, tax rates, revenue growth, and capital expenditures.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Vera Therapeutics' future performance.
  • User-Friendly Design: Designed for industry professionals while remaining approachable for newcomers.

Key Features

  • 🔍 Real-Life VERA Financials: Pre-filled historical and projected data for Vera Therapeutics, Inc. (VERA).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Vera’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Vera’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Model: Download and open the Excel file containing Vera Therapeutics, Inc. (VERA) financial data.
  • 2. Adjust Key Inputs: Modify essential parameters such as revenue projections, discount rates, and operating expenses.
  • 3. Analyze Results in Real-Time: The DCF model automatically computes the intrinsic value and net present value (NPV).
  • 4. Explore Different Scenarios: Evaluate various forecasts to understand potential valuation impacts.
  • 5. Make Informed Decisions: Share expert valuation findings to enhance your investment strategies.

Why Choose Vera Therapeutics, Inc. (VERA)?

  • Innovative Solutions: Pioneering therapies that address unmet medical needs in patients.
  • Expert Team: Led by industry veterans with extensive experience in biotechnology.
  • Robust Pipeline: A diverse range of promising drug candidates in various stages of development.
  • Commitment to Quality: Adherence to the highest standards in research and clinical trials.
  • Positive Impact: Focused on improving patient outcomes and enhancing quality of life.

Who Should Use Vera Therapeutics, Inc. (VERA)?

  • Healthcare Investors: Make informed investment choices with insights from a leading biotech firm.
  • Pharmaceutical Analysts: Streamline your evaluations with comprehensive data on drug development and clinical trials.
  • Consultants: Easily tailor reports and presentations for clients focused on the biotech sector.
  • Biotech Enthusiasts: Enhance your knowledge of therapeutic innovations and market trends with real case studies.
  • Educators and Students: Utilize it as a valuable resource in life sciences and healthcare courses.

What the Template Contains

  • Preloaded VERA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

Es wurden keine passenden Produkte gefunden.